David S. Salomon

15.9k total citations · 2 hit papers
206 papers, 13.0k citations indexed

About

David S. Salomon is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, David S. Salomon has authored 206 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Molecular Biology, 94 papers in Oncology and 30 papers in Genetics. Recurrent topics in David S. Salomon's work include Cancer Cells and Metastasis (52 papers), TGF-β signaling in diseases (32 papers) and HER2/EGFR in Cancer Research (26 papers). David S. Salomon is often cited by papers focused on Cancer Cells and Metastasis (52 papers), TGF-β signaling in diseases (32 papers) and HER2/EGFR in Cancer Research (26 papers). David S. Salomon collaborates with scholars based in United States, Italy and Japan. David S. Salomon's co-authors include Nicola Normanno, Fortunato Ciardiello, Ralf Brandt, Caterina Bianco, Luigi Strizzi, William R. Kidwell, Julius Axelrod, Fusao Hirata, K. Venkatasubramanian and E Schiffmann and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David S. Salomon

204 papers receiving 12.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidermal growth factor-related peptides and their receptors in human malignancies

1995 2.2k citations David S. Salomon, Fortunato Ciardiello et al. profile →
A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.

1980 655 citations David S. Salomon et al. profile →

Peers

Countries citing papers authored by David S. Salomon

Since Specialization

Citations

This map shows the geographic impact of David S. Salomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Salomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Salomon more than expected).

Fields of papers citing papers by David S. Salomon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Salomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Salomon. The network helps show where David S. Salomon may publish in the future.

Co-authorship network of co-authors of David S. Salomon

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Salomon. A scholar is included among the top collaborators of David S. Salomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Salomon. David S. Salomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation 2023 ·Cytotechnology ·Ghmkin Hassan, Said M. Afify, Maram H. Zahra, (unknown), (unknown), Yoshiaki Iwasaki, David S. Salomon, Akimasa Seno, Masaharu Seno	1
2	Sulforaphane Suppresses the Growth of Triple-negative Breast Cancer Stem-like Cells In vitro and In vivo 2019 ·Cancer Prevention Research ·Nadia P. Castro, María Cristina Rangel, Anand S. Merchant, (unknown), Frank Cuttitta, David S. Salomon, Young S. Kim	75
3	Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 2015 ·Cell Death and Differentiation ·Federica Francescangeli, (unknown), Maria Laura De Angelis, Marta Baiocchi, Guido Gambara, Alfredo Pagliuca, Alessandro Fiorenzano, Carolina Prezioso, Alessandra Boe, Matilde Todaro, Giorgio Stassi, Nadia P. Castro, Kazuhide Watanabe, David S. Salomon, Ruggero De Maria, Gabriella Minchiotti, Ann Zeuner	47
4	Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy 2013 ·Journal of Cancer ·Changge Fang, Ingalill Avis, David S. Salomon, Frank Cuttitta	13
5	Human Cripto-1 as a target for a cancer vaccine: WO2008040759 2009 ·Expert Opinion on Therapeutic Patents ·Caterina Bianco, David S. Salomon	6
6	Regulation of Cripto-1 Signaling and Biological Activity by Caveolin-1 in Mammary Epithelial Cells 2008 ·American Journal Of Pathology ·Caterina Bianco, Luigi Strizzi, Mario Mancino, Kazuhide Watanabe, Monica Gonzales, Shin Hamada, Ahmed Raafat, (unknown), Cindy M. Chang, Federica Sotgia, Nicola Normanno, Michael P. Lisanti, David S. Salomon	17
7	Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2 2008 ·Cell Biology International ·(unknown), Takayuki Fukuda, Tadahiro Nagaoka, Hiroko Tada, Hidenori Yamada, Kazuhide Watanabe, David S. Salomon, Masaharu Seno	19
8	Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis 2008 ·Oncogene ·Ahmed Raafat, Sarah K. Lawson, (unknown), Małgorzata Klauzińska, Luigi Strizzi, Anita S. Goldhar, (unknown), David S. Salomon, Barbara K. Vonderhaar, Robert Callahan	46
9	Potential for Cripto-1 in defining stem cell-like characteristics in human malignant melanoma 2008 ·Cell Cycle ·Luigi Strizzi, Daniel E. Abbott, David S. Salomon, Mary J.C. Hendrix	41
10	Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo 2003 ·Journal of Clinical Investigation ·Heather B. Adkins, Caterina Bianco, Susan G. Schiffer, Paul Rayhorn, Mohammad Zafari, Anne E. Cheung, Olivia Orozco, Dian L. Olson, Antonella De Luca, Ling Ling Chen, Konrad Miatkowski, (unknown), Nicola Normanno, Kevin P. Williams, Matthew Jarpe, Doreen LePage, David S. Salomon, Michele Sanicola	134
11	Effect of Exogenous Epidermal-Like Growth Factors on Mammary Gland Development and Differentiation in the Estrogen Receptor-Alpha Knockout (ERKO) Mouse 2003 ·Breast Cancer Research and Treatment ·Nicholas J. Kenney, Arthur Bowman, Kenneth S. Korach, J. Carl Barrett, David S. Salomon	30
12	Growth inhibition of mammalian cells by eosinophil cationic protein 2002 ·European Journal of Biochemistry ·Takashi Maeda, Midori Kitazoe, Hiroko Tada, Rafael de Llorens, David S. Salomon, Masakazu Ueda, Hidenori Yamada, Masaharu Seno	50
13	Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues 1996 ·International Journal of Cancer ·Luigi Panico, Antonio D’Antonio, Gaetano Salvatore, E. Mezza, Giampaolo Tortora, Michelino De Laurentiis, Sabino De Placido, Thomas J. Giordano, Maria J. Merino, David S. Salomon, (unknown), Guido Pettinato, Stuart J. Schnitt, Angelo Raffaele Bianco, Fortunato Ciardiello	93
14	Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas 1995 ·Breast Cancer Research and Treatment ·Nicola Normanno, Nancy Kim, Duanzhi Wen, Kenneth T. Smith, Adrian L. Harris, Gregory D. Plowman, Giulia Colletta, Fortunato Ciardiello, David S. Salomon	66
15	Additive effects of c‐erbB‐2, c‐Ha‐ras, and transforming growth factor‐α genes on in vitro transformation of human mammary epithelial cells 1992 ·Molecular Carcinogenesis ·Fortunato Ciardiello, Marco M. Gottardis, Fulvio Basolo, Stefano Pepe, Nicola Normanno, Robert B. Dickson, Angelo Raffaele Bianco, David S. Salomon	59
16	Expression of transforming growth factor alpha (TGFα) in breast cancer 1991 ·Annals of Oncology ·Fortunato Ciardiello, (unknown), M L McGeady, Daniel S. Liscia, Toshiaki Saeki, Caterina Bianco, David S. Salomon	45
17	Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal Carcinomas 1991 ·Japanese Journal of Cancer Research ·Hiroki Kuniyasu, Kazuhiro Yoshida, Hiroshi Yokozaki, Wataru Yasui, Hisao Ito, Tetsuya Toge, Fortunato Ciardiello, M. Graziella Persico, Toshiaki Saeki, David S. Salomon, Eiichi Tahara	51
18	Over‐expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an Estrogen‐independent phenotype 1990 ·International Journal of Cancer ·Eva M. Valverius, Thierry Velu, Vidya Shankar, Fortunato Ciardiello, Nancy Kim, David S. Salomon	28
19	Transformation of mouse mammary epithelial cells with the Ha‐ras but not with the neu oncogene results in a gene dosage‐dependent increase in transforming growth factor‐α production 1989 ·FEBS Letters ·Fortunato Ciardiello, Nancy E. Hynes, Nancy Kim, Eva M. Valverius, Marc E. Lippman, David S. Salomon	20
20	Modulation by Estrogen and Growth Factors of Transforming Growth Factor-Alpha and Epidermal Growth Factor Receptor Expression in Normal and Malignant Human Mammary Epithelial Cells 1989 ·Recent results in cancer research ·David S. Salomon, William R. Kidwell, (unknown), Fortunato Ciardiello, Susan E. Bates, Eva M. Valverius, Marc E. Lippman, Robert B. Dickson, Martha R. Stampfer	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact